UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of May 2022

Commission File Number: 001-39545

 

 

Orphazyme A/S

(Translation of registrant’s name into English)

 

 

Ole Maaløes Vej 3, DK-2200

Copenhagen N

Denmark

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒  Form 20-F    ☐  Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

 

 

 

EXHIBIT LIST

 

Exhibit

   

Description

99.1    Company announcement dated May 15, 2022

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    Orphazyme A/S
Date: May 16, 2022     By:  

/s/ Anders Vadsholt

      Name Anders Vadsholt
      Title: Chief Financial Officer
Strategic Partners A S (CE) (USOTC:OZYMF)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025 Strategic Partners A S (CE) 차트를 더 보려면 여기를 클릭.
Strategic Partners A S (CE) (USOTC:OZYMF)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025 Strategic Partners A S (CE) 차트를 더 보려면 여기를 클릭.